Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991081 · ClinicalTrials.gov registry record · Phase 4
Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT00991081: Completed Phase 4 study, sponsored by Stanford University.
NCT00991081 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991081, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The major purpose of this exploratory developmental study will be to develop a patient-centered and feasible protocol for communicating genetic data as it relates to drug efficacy for smoking cessation inpatients receiving medication that is matched to individual genotypes associated with increased efficacy for bupropion or nicotine replacement therapy.
Interventions
- BEHAVIORAL Counseling
- BEHAVIORAL Self-help guide
- DRUG Pharmacotherapy
- BEHAVIORAL Genetic feedback, verbal
- BEHAVIORAL Genetic feedback, printed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00991081
The ClinicalTrials.gov registry entry for NCT00991081 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Counseling is the first listed.
NCT00991081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00991081 about?
NCT00991081 is a clinical study titled "Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.". The major purpose of this exploratory developmental study will be to develop a patient-centered and feasible protocol for communicating genetic data as it relates to drug efficacy for smoking cessation inpatients receiving medication that is matched to individual genotypes associated with increased ...
What is the current status of trial NCT00991081?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2009-07. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00991081?
The interventions under investigation include: Counseling (BEHAVIORAL), Self-help guide (BEHAVIORAL), Pharmacotherapy (DRUG), Genetic feedback, verbal (BEHAVIORAL), Genetic feedback, printed (BEHAVIORAL).
Who is sponsoring clinical trial NCT00991081?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.